Spots Global Cancer Trial Database for taxol
Every month we try and update this database with for taxol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | NCT00001569 | Carcinoma Peritoneal Neop... | Cisplatin Paclitaxel 5-FU | - | National Institutes of Health Clinical Center (CC) | |
| Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer | NCT05185947 | Gynecologic Can... Gynecologic Neo... Peritoneal Carc... Peritoneal Neop... Ovarian Cancer Ovarian Neoplas... Colorectal Canc... Colorectal Neop... Appendiceal Can... Appendiceal Neo... | Paclitaxel Nilotinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| MPDL3280A With Chemoradiation for Lung Cancer | NCT02525757 | Lung Cancer Non-Small Cell ... | MPDL3280A Carboplatin Paclitaxel Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | NCT00505492 | Uterine Neoplas... | Carboplatin Cisplatin Paclitaxel | - | M.D. Anderson Cancer Center | |
| Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel | NCT00039780 | Breast Neoplasm... Breast Diseases Metastases, Neo... | BNP7787 Placebo | 18 Years - | BioNumerik Pharmaceuticals, Inc. | |
| Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer | NCT00080418 | Neoplasm | Liposome Entrap... | 18 Years - | INSYS Therapeutics Inc | |
| Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer | NCT04238988 | Locally Advance... | Pembrolizumab Carboplatin Taxol | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer | NCT00394251 | Breast Cancer | Adriamycin and ... ABI-007 Taxol Bevacizumab pegfilgrastim | 18 Years - 70 Years | Celgene | |
| Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy | NCT03315364 | Recurrent or Me... | Oral paclitaxel Paclitaxel inje... | 19 Years - | Daehwa Pharmaceutical Co., Ltd. | |
| A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian | NCT01952249 | Primary Periton... | Demcizumab Taxol | 21 Years - 90 Years | Mereo BioPharma | |
| Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer | NCT00308178 | Breast Cancer | Abraxane | 18 Years - | Dana-Farber Cancer Institute | |
| Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer | NCT00102622 | Ovarian Cancer | Intraperitoneal... Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer | NCT00251095 | Breast Neoplasm | Taxol TOCOSOL Paclita... | 18 Years - | Achieve Life Sciences | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | NCT00495170 | Lung Cancer | Carboplatin Proton Radiothe... Paclitaxel | - | M.D. Anderson Cancer Center | |
| Papillary Serous Carcinoma of the Endometrium | NCT00515073 | Endometrial Can... | Paclitaxel Pelvic Radiatio... Dexamethasone Cimetidine Diphenhydramine | - | M.D. Anderson Cancer Center | |
| Lenalidomide and Paclitaxel in Prostate Cancer | NCT00933426 | Prostate Cancer | Lenalidomide Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L) | NCT01497665 | Non-small Cell ... | GRN1005 | 18 Years - | Angiochem Inc | |
| Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer | NCT00146549 | Breast Cancer Stage IV Breast... | Trastuzumab Vinorelbine Paclitaxel Docetaxel | 18 Years - | Dana-Farber Cancer Institute | |
| GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases | NCT01480583 | Breast Cancer Brain Metastase... | GRN1005 Trastuzumab 18F-FLT | 18 Years - | Angiochem Inc | |
| Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus | NCT00502203 | Mixed Tumor, Mu... | Carboplatin Paclitaxel | - | M.D. Anderson Cancer Center | |
| Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | NCT00050167 | Breast Cancer | Paclitaxel Docetaxel Capecitabine | - | M.D. Anderson Cancer Center | |
| Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement | NCT00508326 | Advanced Cancer | Paclitaxel | 13 Years - | M.D. Anderson Cancer Center | |
| Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer | NCT00876070 | Metastatic Brea... | 18 Years - | SCRI Development Innovations, LLC | ||
| Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors | NCT00113438 | Cancer Tumor | Combretastatin ... | 18 Years - | Mateon Therapeutics | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer | NCT00614484 | Locally Advance... | Proton Radiatio... Taxol Carboplatin | 18 Years - | Loma Linda University | |
| A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer | NCT00001442 | Head and Neck N... Squamous Cell C... | paclitaxel conc... | - | National Institutes of Health Clinical Center (CC) | |
| Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer | NCT00100139 | Neoplasm | Liposome Entrap... Paclitaxel for ... | 18 Years - | INSYS Therapeutics Inc | |
| Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer | NCT02072317 | Advanced Gastri... | taxel plus ralt... taxol | 18 Years - 75 Years | Fudan University | |
| Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer | NCT00588237 | Ovarian Cancer Primary PERITON... Fallopian Tube ... | Paclitaxel,Cisp... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer | NCT00445458 | Advanced Breast... Advanced Malign... Breast Neoplasm... | HKI-272 Paclitaxel | 18 Years - | Puma Biotechnology, Inc. | |
| Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | NCT00505492 | Uterine Neoplas... | Carboplatin Cisplatin Paclitaxel | - | M.D. Anderson Cancer Center | |
| Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix | NCT00626561 | Cervical Cancer Uterine Cancer | Bevacizumab Paclitaxel | - | M.D. Anderson Cancer Center | |
| Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 | NCT00004067 | Breast Cancer | herceptin adriamycin cyclophosphamid... taxol | 18 Years - | NSABP Foundation Inc | |
| Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma | NCT00506779 | Uterine Cancer | Imatinib Mesyla... Paclitaxel | - | M.D. Anderson Cancer Center | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 | NCT00004067 | Breast Cancer | herceptin adriamycin cyclophosphamid... taxol | 18 Years - | NSABP Foundation Inc | |
| Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | NCT00038402 | Breast Cancer | Herceptin Taxol Fluorouracil Cytoxan Epirubicin | - | M.D. Anderson Cancer Center | |
| Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer | NCT00251095 | Breast Neoplasm | Taxol TOCOSOL Paclita... | 18 Years - | Achieve Life Sciences | |
| A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer | NCT02662634 | Non-small Cell ... | AGS-003-LNG Carboplatin Abraxane Alimta Cisplatin Taxol Radiation Thera... | 19 Years - | GU Research Network, LLC | |
| Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | NCT00038168 | Prostate Cancer | Estramustine Taxol | - | M.D. Anderson Cancer Center | |
| Lenalidomide and Paclitaxel in Prostate Cancer | NCT00933426 | Prostate Cancer | Lenalidomide Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies | NCT01015222 | Advanced Cancer | Dasatinib Bevacizumab Paclitaxel | - | M.D. Anderson Cancer Center | |
| Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer | NCT00102622 | Ovarian Cancer | Intraperitoneal... Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer | NCT00073723 | Non-Small Cell ... | ABI-007 | 18 Years - | Celgene Corporation | |
| Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer | NCT00876070 | Metastatic Brea... | 18 Years - | SCRI Development Innovations, LLC | ||
| A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | NCT00378313 | Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IV Breast... Breast Cancer Locally Advance... | gemcitabine, ep... | 18 Years - | NSABP Foundation Inc | |
| Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) | NCT00388076 | Neoplasms, Brea... | Pazopanib Lapatinib paclitaxel carboplatin | 18 Years - | GlaxoSmithKline | |
| Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer | NCT00100139 | Neoplasm | Liposome Entrap... Paclitaxel for ... | 18 Years - | INSYS Therapeutics Inc | |
| BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) | NCT00533585 | Lung Cancer | BAY 43-9006 Paclitaxel Carboplatin Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Alpha-Lipoic Acid in Breast Cancer Patients | NCT03908528 | Breast Cancer Chemotherapeuti... | Alpha-lipoic ac... Placebo Plus Ch... | 18 Years - 70 Years | Damanhour University | |
| A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy | NCT01839773 | Stage IV Gastri... | Paclitaxel Paclitaxel | 20 Years - | Daehwa Pharmaceutical Co., Ltd. | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00004093 | Lung Cancer | carboplatin Gemcitabine paclitaxel vinorelbine radiation thera... Navelbine Taxol | 18 Years - | Northwestern University | |
| A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer | NCT00001442 | Head and Neck N... Squamous Cell C... | paclitaxel conc... | - | National Institutes of Health Clinical Center (CC) | |
| Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | NCT00046527 | Breast Neoplasm... Metastases, Neo... | ABI-007 | 16 Years - | Celgene Corporation | |
| EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) | NCT00270790 | Head and Neck C... | Amifostine Carboplatin Taxol Radiotherapy | 18 Years - | University of Maryland, Baltimore | |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients | NCT01238562 | Chemotherapy Pa... | YPEG-Filgrastim YPEG-Filgrastim YPEG-Filgrastim YPEG-Filgrastim YPEG-Filgrastim | 18 Years - 70 Years | Xiamen Amoytop Biotech Co., Ltd. | |
| Study of Vemurafenib, Carboplatin, and Paclitaxel | NCT01636622 | Advanced Cancer... | Vemurafenib Carboplatin Paclitaxel | 12 Years - | M.D. Anderson Cancer Center | |
| A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | NCT00378313 | Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IV Breast... Breast Cancer Locally Advance... | gemcitabine, ep... | 18 Years - | NSABP Foundation Inc | |
| Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer | NCT00876070 | Metastatic Brea... | 18 Years - | SCRI Development Innovations, LLC | ||
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | NCT00001569 | Carcinoma Peritoneal Neop... | Cisplatin Paclitaxel 5-FU | - | National Institutes of Health Clinical Center (CC) | |
| Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement | NCT00508326 | Advanced Cancer | Paclitaxel | 13 Years - | M.D. Anderson Cancer Center | |
| Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs | NCT01208545 | Chemotherapy Nerve Degenerat... Nerve Conductio... | 18 Years - 80 Years | NeuroMetrix, Inc. | ||
| Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer | NCT02072317 | Advanced Gastri... | taxel plus ralt... taxol | 18 Years - 75 Years | Fudan University | |
| Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer | NCT01256762 | Locally Recurre... | Imetelstat sodi... Bevacizumab Paclitaxel | 18 Years - | Geron Corporation | |
| Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer | NCT01256762 | Locally Recurre... | Imetelstat sodi... Bevacizumab Paclitaxel | 18 Years - | Geron Corporation | |
| Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin | NCT00652119 | Ovarian Cancer Peritoneal Canc... Fallopian Tube ... | Paclitaxel Carboplatin Avastin | 18 Years - | Massachusetts General Hospital | |
| Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) | NCT02044601 | Lung Cancer | Onartuzumab Erlotinib Paclitaxel Carboplatin Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) | NCT00196872 | Breast Cancer | Epirubicine Cyclophosphamid... Taxol Xeloda Ibandronat | 18 Years - 65 Years | German Breast Group | |
| "Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients" | NCT05189535 | Breast Cancer F... Peripheral Neur... | Pentoxifylline Paclitaxel Placebo | 18 Years - 80 Years | Ain Shams University | |
| Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | NCT00046527 | Breast Neoplasm... Metastases, Neo... | ABI-007 | 16 Years - | Celgene Corporation | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib | NCT00272987 | Neoplasms, Brea... | lapatinib paclitaxel trastuzumab | 18 Years - | Novartis | |
| Study of Vemurafenib, Carboplatin, and Paclitaxel | NCT01636622 | Advanced Cancer... | Vemurafenib Carboplatin Paclitaxel | 12 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | NCT01593020 | Breast Cancer | Paclitaxel Eribulin 5-Fluorouracil Epirubicin Cyclophosphamid... Doxorubicin | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | NCT00050167 | Breast Cancer | Paclitaxel Docetaxel Capecitabine | - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
